An Open Label Comparing the Short Term Efficacy of Lacrisert

Status unconfirmed · Phase 4

Conditions studied: Dry Eye

In brief

To evaluate the short term effects of LACRISERT®. upon fluorescein corneal staining, tear osmolarity and surface topography in human subjects with dry eye disease.

Key facts

Study ID

NCT03079271

Run by

Virginia Eye Consultants

People needed

50

Starts

2016-11-01

Expected to finish

2017-12-01

Last updated by the study team

2017-03-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Has Dry Eye disease indicated by a staining score of ≥ 4 and Speed score of >6

You may not qualify if…

• Concurrent involvement in any other clinical trial
• Anticipated contact lens wear during the study and 14hours prior to Day -History of corneal transplant
• Active ocular infection, uveitis or non-KCS inflammation
• History of recurrent herpes keratitis or active disease within the last six months
• Topical ophthalmic medications during the study
• Temporary collagen punctal plugs within one week prior to study.

Where it is running

• Virginia Eye Consultants — Norfolk, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.